We are live on ! Find out more
OFM

Omega Fund Management Portfolio holdings

AUM $163M
1-Year Est. Return 107.06%
This Fund
S&P 500
This Quarter Est. Return
+5.86%
1 Year Est. Return
+107.06%
3 Year Est. Return
+111.75%
5 Year Est. Return
+84.24%
10 Year Est. Return
+495.59%
AUM
$180M
AUM Growth
+$2.07M
Cap. Flow
-$4.61M
Cap. Flow %
-2.56%
Top 10 Hldgs %
100%
Holding
10
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
EGLT
Egalet Corporation
EGLT
+$1.68M

Top Sells

Rank Stock Value
1
JUNO
Juno Therapeutics, Inc.
JUNO
+$4.96M
2
KYNB
Kyntra Bio
KYNB
+$1.33M

Sector Composition

Rank Sector Weight
1 Healthcare 68.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JUNO
1
DELISTED
Juno Therapeutics, Inc.
JUNO
$54.1M 30.09%
1,229,512
-100,000
-8% -$4.96M
PRTK
2
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$40.6M 22.58%
2,138,872
– –
EGLT
3
DELISTED
Egalet Corporation
EGLT
$31M 17.26%
2,814,928
+169,370
+6% +$1.68M
KYNB
4
Kyntra Bio
KYNB
$28.5M
$25.1M 13.94%
32,887
-2,000
-6% -$1.33M
NBRV
5
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$11M 6.13%
4,584
– –
PVLA
6
Palvella Therapeutics
PVLA
$1.98B
$5.69M 3.17%
31,049
– –
EPIX
7
DELISTED
ESSA Pharma
EPIX
$4.64M 2.58%
54,545
– –
TARA icon
8
Protara Therapeutics
TARA
$226M
$3.88M 2.16%
6,250
– –
DRNA
9
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.65M 1.48%
223,457
– –
CBAY
10
DELISTED
Cymabay Therapeutics
CBAY
$1.1M 0.61%
650,000
– –

Similar funds

HCCM
Hudson Canyon Capital Management New York $163M AUM 33.71% 1-Year Est. Return
PBO
Peoples Bank (Ohio) Marietta, Ohio $163M AUM 18.72% 1-Year Est. Return
PCR
Potrero Capital Research San Francisco, California $163M AUM 79.07% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
IVGAI
Index Venture Growth Associates IV St. Helier, Jersey $163M AUM 54.88% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
TCGDR
TB Capital Gestao de Recursos Rio De Janeiro $163M AUM 20.86% 1-Year Est. Return
IPWA
International Private Wealth Advisors San Diego, California $163M AUM 16.99% 1-Year Est. Return

Omega Fund Management's Q4 2015 Portfolio in Review

As of Q4 2015, Omega Fund Management held 10 positions worth $180M, up 1.2% from $178M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q4 2015: portfolio turnover was 0%. Omega Fund Management opened no new positions and made no exits, leaving the 10-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 68% of assets, down from 69% a quarter earlier.

  • Omega Fund Management added most to Egalet Corporation in Q4 2015, an estimated $1.68M increase.
  • Omega Fund Management's biggest Q4 2015 reduction was Juno Therapeutics, Inc., cutting an estimated $4.96M.
  • Omega Fund Management's ten largest holdings make up 100% of its $180M portfolio in Q4 2015.
  • Omega Fund Management opened 0 new positions and closed 0 in Q4 2015.
  • Omega Fund Management's portfolio value rose 1.2% quarter-over-quarter to $180M.

Based on Omega Fund Management's 13F filing for Q4 2015, filed 10 Feb 2016.